Insurance companies should not dictate which medical devices physicians prescribe.
Diabetes patients voice outrage and the diabetes community has been set ablaze after UnitedHealthcare announced an agreement for Medtronic devices to be the “preferred” in-network, durable medical equipment (DME) provider of insulin pumps. Starting July 1, 2016, UnitedHealthcare patients will be funneled toward using a Medtronic insulin pump instead of offerings from manufacturers like Tandem and Animas.
#MyPumpMyChoice and #AccessMatters, and I strongly echo their sentiment that this policy puts “profits before patients.” It’s unacceptable, and both UnitedHealthcare and Medtronic deserve any negative publicity that results from such a short-sighted decision.Many diabetes advocates have eloquently voiced their outrage and have been rallying under the hashtags
“That’s why we must act now and make it clear that we will not take it lightly when insurance companies try to dictate which medical devices we use and prescribe.”
Sourced through Scoop.it from: www.kevinmd.com